Viracta Therapeutics, Inc. Quarterly Operating Lease, Liability in USD from Q3 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Viracta Therapeutics, Inc. quarterly Operating Lease, Liability history and growth rate from Q3 2018 to Q2 2024.
  • Viracta Therapeutics, Inc. Operating Lease, Liability for the quarter ending June 30, 2024 was $73K, a 84.6% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $73K -$402K -84.6% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $179K -$384K -68.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $282K +$4K +1.44% Dec 31, 2023 10-K 2024-03-07
Q3 2023 $381K +$381K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $475K +$1K +0.21% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $563K -$4K -0.71% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $278K -$381K -57.8% Dec 31, 2022 10-K 2023-03-14
Q3 2022 $0.40* -$748K Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $474K -$358K -43% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $567K -$1.05B Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $659K -$438K -39.9% Dec 31, 2021 10-K 2022-03-17
Q3 2021 $748K +$339K +82.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $832K +$165K +24.7% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.05B* +$1.05B Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.1M +$280K +34.3% Dec 31, 2020 8-K/A 2021-03-23
Q3 2020 $409K -$545K -57.1% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $667K -$423K -38.8% Jun 30, 2020 8-K/A 2021-03-23
Q1 2020 $681K -$545K -44.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $817K Dec 31, 2019 10-K 2020-03-10
Q3 2019 $954K +$729K +324% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $1.09M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.23M Mar 31, 2019 10-Q 2019-05-08
Q3 2018 $225K Sep 1, 2018 8-K/A 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.